Trial Enrollment and Follow-Up
cancer, pain
CANCER, SOLID TUMORS
LTFU indicates lost to follow-up.The demographic and clinical characteristics of the patients in the 2 groups were similar at baseline. The mean (SD) age of the patients was 58.7 (14.1) years, 200 (67.1%) were women, and 98 (32.9%) were men. Self-reported race and ethnicity, as categorized herein, were included to ensure diversity among research participants: 19 individuals (6.4%) were Asian, 33 (11.1%) were Black, 46 (15.4%) were Hispanic, 220 (74.1%) were White, and 25 (8.4%) were multiracial.A total of 78.5% of the patients had solid tumors. The most common cancer types were hematologic (21.5%), breast (19.8%), gynecologic (14.4%), and gastrointestinal (11.7%). Mean (SD) time since diagnosis was 5.6 (7.5) years. The mean (SD) score for worst pain severity was 6.9 (1.5), the mean (SD) pain duration was 3.8 (7.3) years, and 98 individuals (32.9%) were receiving opioids at baseline (